Instructor in Medicine, Dana-Farber Cancer Institute

Oncology

Dr. Thomas A. Abrams, MD

Thomas A. Abrams, MD practices Oncology. He went to medical school at Jefferson Medical College. Doctor Thomas A. Abrams, MD is also published. He has 21 publications published. The lastest publication: "A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma.' Dr. Thomas A. Abrams is registered with Medicare and accepts Medicare payments.

Publications

A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular Carcinoma.
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder Cancer.
Chemotherapy Usage Patterns in a US-Wide Cohort of Patients With Metastatic Colorectal Cancer.
A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine Tumors.
Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer.
Multi-drug inhibition of the HER pathway in metastatic colorectal Cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients.
Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study.
First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma.
Feasibility of computer-based self-administered Cancer-specific geriatric assessment in older patients with gastrointestinal malignancy.
Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine Tumors.
Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer.
A phase 2 study of oral MKC-1, an inhibitor of importin-?, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic Cancer.
Patterns of Adjuvant Chemotherapy Use in a Population-Based Cohort of Patients With Resected Stage II or III Colon Cancer.
Phase 1/2 study of everolimus in advanced hepatocellular Carcinoma.
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid Tumors.
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular Carcinoma: a phase II study.
NCCN clinical practice guidelines in oncology: hepatobiliary Cancers.
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic Cancer.
Targeted therapy for dermatofibrosarcoma protuberans.
Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic Cancer may not impact local control.

Schools

Jefferson Medical College Of Thomas Jefferson University Thomas Jefferson University
University Of Michigan

Procedures Preformed

Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Thoracentesis

Conditions Treated

Adrenal Gland Cancer
Anal and Rectal Cancer
Anemia
Bile Duct Cancer
View All

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Education

University of Michigan Hospitals and Health Centers
Jefferson Medical College

Hospital

Brigham and Women's Hospital
Dana-Farber Cancer Institute

Drug Facts

NPI NUMBER		1184693947
NPPES Provider LastName		ABRAMS
NPPES Provider FirstName		THOMAS
NPPES Provider ZIPCode		021156013
NPPES Provider State		MA
Specialty Description		Medical Oncology
Total Claim Count		417.0
Distinct Opioid Count		1.0
Opioid Claim Count		34.0
Percent Opioid Claims		8.15

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1184693947
Last Name Of The Provider	ABRAMS
First Name Of The Provider	THOMAS
View All

Similar Doctors

	Dr. Nicholas J. Short, MD This Doctor is OpenDoctor Recommended.
	Dr. Alice T. Shaw, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Dimitrios Spentzos, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kathryn J. Ruddy, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Myles A. Brown, MD This Doctor is OpenDoctor Recommended.
	Dr. Pankaj Bhargava, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven J. Isakoff, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Eliezer M. VanAllen, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael J. Birrer, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ken S. Zaner, MD This Doctor is OpenDoctor Recommended. This doctor has more publications